<DOC>
	<DOCNO>NCT00170300</DOCNO>
	<brief_summary>The CARE-HF trial evaluate effect Cardiac Resynchronization ( CR ) therapy mortality morbidity patient heart failure due leave ventricular systolic dysfunction already receive diuretic optimal medical therapy .</brief_summary>
	<brief_title>Care-HF CArdiac Resynchronization Heart Failure</brief_title>
	<detailed_description>813 patient enrol 82 center 12 country ( Austria , Belgium , Denmark , Finland , France , Germany , Italy , Netherlands , Spain , Sweden , Switzerland , UK )</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Heart failure least 6 week require loop diuretic Currently NYHA class III/IV A high standard pharmacological therapy LV systolic dysfunction dilation ( EF &lt; =35 % ; EDD &gt; 30mm/height metre ) QRS &gt; =120 m Dyssynchrony confirm echo QRS 120149 m ( Aortic preejection delay &gt; 140ms , Interventricular mechanical delay &gt; 40 m , Delayed activation posterolateral LV wall ) Age &lt; 18 year old age &lt; legal age define country case different Chronic atrial fibrillation within 6 week prior randomization ; Impairment leave ventricular function relate leave ventricular systolic function Potentially reversible form cardiomyopathy : Cardiac surgery , percutaneous coronary intervention , cardiomyoplasty , myocardial infarction , unstable severe angina stroke within 6 week randomization A conventional indication bradyarrhythmia pace exists ; A conventional indication ICD exist A pacemaker ICD already implant ; InPatients require continuous intravenous therapy Heart Failure ; Life expectancy &lt; 1 year disease unrelated Heart Failure ; Pregnancy childbearing potential reliable contraceptive ; Mechanical tricuspid valve ; Anticipated compliance problem participation another trial ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Cardiac resynchronisation therapy ( CRT therapy ) ,</keyword>
	<keyword>all-cause mortality ,</keyword>
	<keyword>quality life assesment ,</keyword>
	<keyword>echocardiographic leave ventricular function ,</keyword>
	<keyword>CRT neurohormonal activation ,</keyword>
	<keyword>CRT health economics</keyword>
</DOC>